GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's quarterly cash and cash equivalents declined from Dec. 2013 ($9,117 Mil) to Mar. 2014 ($5,886 Mil) and declined from Mar. 2014 ($5,886 Mil) to Jun. 2014 ($5,398 Mil).
GlaxoSmithKline PLC's annual cash and cash equivalents declined from Dec. 2011 ($8,873 Mil) to Dec. 2012 ($6,684 Mil) but then increased from Dec. 2012 ($6,684 Mil) to Dec. 2013 ($9,117 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data